Vor Biopharma Inc.

VOR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$160,462$190,574$50,047$81,949
Short-Term Investments$10,000$9,991$9,988$9,977
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,024$4,362$4,812$4,581
Total Curr. Assets$172,486$204,927$64,847$96,507
Property Plant & Equip (Net)$3,314$24$39,683$41,588
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$168$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$269$420$4,782$14,923
Total NC Assets$3,751$444$44,465$56,511
Other Assets$0$0$0-$10,127
Total Assets$176,237$205,371$109,312$142,891
Liabilities
Payables$885$669$3,732$1,505
Short-Term Debt$252$0$4,266$4,215
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$17,702$58,104$8,729$12,892
Total Curr. Liab.$18,839$58,773$16,727$18,612
LT Debt$2,807$0$26,516$27,615
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,380,078$1,652,298$0$0
Total NC Liab.$2,382,885$1,652,298$26,516$27,615
Other Liabilities$0$0$0$0
Cap. Leases$2,807$0$30,782$31,830
Total Liabilities$2,401,724$1,711,071$43,243$46,227
Equity
Pref Stock$0$0$0$0
Common Stock$15$13$13$13
Retained Earnings-$2,875,833-$2,063,149-$489,480-$456,994
AOCI$12$14$23$22
Other Equity$650,319$557,422$555,513$553,623
Total Equity-$2,225,487-$1,505,700$66,069$96,664
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$176,237$205,371$109,312$142,891
Net Debt-$157,403-$190,574-$19,265-$50,119